| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.28 | 0.09 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |